Meta-analysis of 21 studies (21,506 patients) with cirrhosis and portal vein thrombosis: vs VKAs, DOACs were associated with more complete recanalisation (RR 3.49) and less progression (RR 0.19), with no significant difference in major bleeding.
Meta-analysisn = 21,506
Boccatonda et al. Direct oral anticoagulants in portal vein thrombosis in patients with cirrhosis: a systematic review and meta-analysis